Journal of Controlled Release

Aims & Scope

The Journal of Controlled Release (JCR) publishes high-quality research articles in the broad field of delivery science and technology.

This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.

Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.

Each issue has the cover story highlighting the significance of a selected article published in the issue.

At the end of each quarter, the JCR editors select "The Editors' Choice" from the published research articles.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	11.5
2024	10.50

Journal Rank

Year	Value
2024	976

Journal Citation Indicator

Year	Value
2024	24422

SJR (SCImago Journal Rank)

Year	Value
2024	2.470

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	327

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

  Citation: 5541

  Authors: H, J, T, Y, K

• Doxil® — The first FDA-approved nano-drug: Lessons learned

  Citation: 3931

  Authors: Yechezkel (Chezy)

• DLS and zeta potential – What they are and what they are not?

  Citation: 3413

  Authors: Sourav

• A simple equation for description of solute release II. Fickian and anomalous release from swellable devices

  Citation: 3310

  Authors: Philip L., Nikolaos A.

• A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs

  Citation: 3194

  Authors: Philip L., Nikolaos A.

• PLGA-based nanoparticles: An overview of biomedical applications

  Citation: 2960

  Authors: Fabienne, Eduardo, Joana M., Régis, Aude, Véronique

• Biodegradable polymeric nanoparticles as drug delivery devices

  Citation: 2774

  Authors: Kumaresh S, Tejraj M, Anandrao R, Walter E

• To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

  Citation: 2325

  Authors: Fabienne, Olivier, Véronique

• Recent advances on chitosan-based micro- and nanoparticles in drug delivery

  Citation: 2089

  Authors: Sunil A., Nadagouda N., Tejraj M.

• Toxicity of cationic lipids and cationic polymers in gene delivery

  Citation: 1953

  Authors: Hongtao, Shubiao, Bing, Shaohui, Jie

---